Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AAHP-HIAA completes merger

Executive Summary

American Association of Health Plans and Health Insurance Association of America complete merger Dec. 11; the association will be known temporarily as AAHP-HIAA. The association is also moving its Washington, D.C. headquarters to 601 Pennsylvania Ave., NW. AAHP CEO Karen Ignagni will continue as head of the combined group (1"The Pink Sheet" Sept. 29, 2003, p. 14)...

You may also be interested in...



GPhA adds lobbyist

Generic Pharmaceutical Association's chief federal lobbyist will be Stephen Mason, who joins as director-federal government affairs. Mason was formerly federal legislative director for the Health Insurance Association of America, which recently merged with the American Association of Health Plans (1"The Pink Sheet" Dec. 15, 2003, In Brief). Mason brings experience working with Republican officials and candidates, including Sen. John Ensign (R-Nev.)...

Medicare Rx Implementation Team: AAHP Lobbyist Will Head “Outreach”

AAHP-HIAA Senior VP Julie Goon will join the Bush Administration to oversee outreach efforts to support the new Medicare prescription drug law

AAHP, HIAA Merger Will Give Insurance Firms Unified Voice On Rx Issues

The proposed merger of the American Association of Health Plans and the Health Insurance Association of America will give the insurance industry a unified voice on pharmaceutical issues

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042967

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel